Litigation Details for DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE (D.N.J. 2015)

DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE (D.N.J. 2015)

Docket		Date Filed	2015-11-11
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Susan Davis Wigenton
Jury Demand	None	Referred To	Magistrate Judge Leda D. Wettr
Patents	9,023,391
Link to Docket	External link to docket

Details for DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE (D.N.J. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-11-11	1		United States Patent Nos. 9,023,391 (“the ’391 patent”) and 7,255,878 (“the ’878 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-in-suit 9. On May 5, 2015, the United States Patent and Trademark …issued the ’391 patent, entitled “Stable Benzimidazole Formulation.” A copy of the ’391 patent is attached…issued the ’878 patent, entitled “Stable Benzimidazole Formulation.” A copy of the ’878 patent is attached	External link to document
2017-03-13	88		regarding patent claims in Plaintiffs’ U.S. Patent Nos. 7,255,878 (“the ’878 patent”) and 9,023,391 (“the…regarding the request for a patent claim construction pursuant to Local Patent Rule 4.5(a). …the ’391 patent”) (collectively, “the patents-in-suit”). After carefully considering the parties’ written…) infringement of the ’391 patent and (II) infringement of the ’878 patent. (Compl. 1 Markman …claim phrases: three in the ‘878 patent and two in the ‘391 patent. Defendants offer proposed constructions	External link to document